Olivarez, Alexa N.
Yang, Cathy Z.
Zhou, Liwen
Mikesh, Michelle
Ghergherehchi, Cameron L.
Garcia, Henry A.
Schafer, Alexander M.
Periyasamy, Guhan
Nguyen, Phuong Vy
Hao, Yiming
Agarwal, Arjun
Gokhale, Varun
Sood, Rhea
Nagarajan, Neha
Sanklipur, Sushant
Bittner, George D. https://orcid.org/0000-0002-5610-6264
Funding for this research was provided by:
National Instiute of Health (R01-NS128086)
Lone Star Paralysis Foundation (Lone Star Paralysis Foundation)
Article History
Received: 4 February 2026
Accepted: 29 June 2026
First Online: 15 July 2026
Declarations
Ethical approval: All experimental procedures adhered to the National Institutes of Health Guide for the Care and Use of Laboratory Animals (8th ed., National Research Council, 2011) and were approved by the Institutional Animal Care and Use Committee at The University of Texas at Austin (AUP20252200278, approved 02/07/2025).
Consent for publication: Not applicable.
Competing interests: GDB, CZY, ANO, and LZ have provided data for patents on PEG-fusion repair of peripheral nerve injuries owned by The University of Texas at Austin (UTA). They have recently formed NeuCo Therapeutics to begin commercializing some of these patents. UTA and NeuCo Therapeutics had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.